Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 3, 2026, 11:32 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 121–144 of 1,131 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Functional MRI Clear all

Conditions: Multiple Sclerosis
Interventions: 7T MRI, Neurocognitive testing; Diagnostic Test
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years to 50 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Spinal Cord Injuries
Interventions: Functional Electric Stimulation cycling, Passive cycling; Device
Lead sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.; Other
Eligibility: 18 Years to 65 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Irritable Bowel Syndrome
Interventions: Not listed
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 10 Years to 18 Years
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2013
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: PTSD
Interventions: Trauma Management Therapy, Exposure Therapy with Psychotherapy group; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Salem, Virginia

Conditions: Healthy Subject, Stage 0 Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer
Interventions: Biospecimen Collection, Functional Magnetic Resonance Imaging, Questionnaire Administration; Procedure · Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 178 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Major Depressive Disorder, Chronic Major Depression, Recurrent
Interventions: Sertraline; Drug
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years to 65 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Austin, Texas

Conditions: ADHD
Interventions: fMRI Neurofeedback attention task; Combination Product
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 12 Years to 35 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Brookline, Massachusetts

Conditions: Cocaine Dependence
Interventions: Acthrel; Drug
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 65 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Pulmonary Disease, Pulmonary Hypertension
Interventions: Not listed
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: 18 Years to 100 Years
Enrollment: 270 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2013
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Obesity
Interventions: hydrocortisone, saline; Drug · Other
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 45 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Functional Magnetic Resonance Imaging
Interventions: Not listed
Lead sponsor: Neurological Associates of West Los Angeles; Other
Eligibility: 18 Years to 65 Years
Enrollment: 2,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2030
U.S. locations: 1
States / cities: Santa Monica, California

Conditions: Developmental Psychology
Interventions: Not listed
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 2 Months to 60 Years
Enrollment: 550 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2003
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Mild Cognitive Impairment
Interventions: Meal-Replacement Therapy, Dietary Counseling; Dietary Supplement · Behavioral
Lead sponsor: Iowa State University; Other
Eligibility: 70 Years to 85 Years
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 2
States / cities: Ames, Iowa • Iowa City, Iowa

Conditions: Alcohol Use Disorder, Attention Deficit Hyperactivity Disorder
Interventions: Methylphenidate Pill; Drug
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 25 Years
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Obesity
Interventions: Naltrexone SR 32 mg/bupropion SR 360 mg/day, Placebo, fMRI scan; Drug · Other
Lead sponsor: Orexigen Therapeutics, Inc; Industry
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Upton, New York

Conditions: Drug Dependence
Interventions: Cognitive Behavioral Therapy, Intranasal Oxytocin, Placebo; Behavioral · Drug
Lead sponsor: National Institute on Drug Abuse (NIDA); NIH
Eligibility: 18 Years to 65 Years
Enrollment: 63 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Depression Mild, Depression, Depression Moderate
Interventions: Matter Neuroscience App, Stock Photos, No Home Training, Personal Photos, Home Training; Device · Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Stanford, California

Conditions: Chronic Heart Failure (CHF)
Interventions: LCZ696, Valsartan, Placebo of LCZ696, Placebo of Valsartan; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 60 Years and older
Enrollment: 592 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 52
States / cities: Andalusia, Alabama • Glendale, Arizona • Mesa, Arizona + 45 more

Conditions: Parkinson Disease
Interventions: Exercise; Other
Lead sponsor: Sule Tinaz; Other
Eligibility: 40 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Healthy, Magnetic Resonance Imaging
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 18 Years and older
Enrollment: 102 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2010
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Cerebral Small Vessel Diseases
Interventions: hyperbaric oxygen treatment; Other
Lead sponsor: St. Luke's Hospital, Chesterfield, Missouri; Other
Eligibility: 50 Years to 90 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 3
States / cities: Chesterfield, Missouri • St Louis, Missouri

Conditions: Voiding Disorders
Interventions: Simultaneous functional MRI and urodynamic studies, Questionnaires, Post Void Residual (PVR), Uroflow and Bladder Diary, Urinalysis; Diagnostic Test · Behavioral · Other
Lead sponsor: The Methodist Hospital Research Institute; Other
Eligibility: 45 Years to 90 Years · Male only
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Tongue Carcinoma
Interventions: MRI; Procedure
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 21 Years to 75 Years
Enrollment: 99 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Healthy, Attention
Interventions: docosahexaenoic acid; Dietary Supplement
Lead sponsor: University of Cincinnati; Other
Eligibility: 8 Years to 10 Years · Male only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Cincinnati, Ohio

Search by objective public record fields.

Gilenya's Impact on Cognitive Function and Thalamic Volumes

Investigation of Brain Functional MRI as an Early Biomarker of Recovery in Individuals With Spinal Cord Injury

Use of Functional Magnetic Resonance Imaging (fMRI) to Study Brain Activation in Children With Irritable Bowel Syndrome

Efficacy and Neural Mediators of Response to Trauma Management Therapy for PTSD

Functional Magnetic Resonance Imaging in Assessing Affect Reactivity and Regulation in Patients With Stage 0-III Breast Cancer

Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression

Impact of Stimulants and In-Scanner Motion on Attentive Task Performance in ADHD (ADHD_NFB)

Gender and Neural Substrates of Stress and Craving

Natural History Study of Biomarkers in Pulmonary Arterial Hypertension

Investigating the Central and Peripheral Mechanisms by Which Glucocorticoids Affect Hunger

Study for the Evaluation of the Feasibility of Applying Advanced MRI Scanning in Clinical Practice

The Psychobiology of Childhood Temperament

Calorie Restriction and Brain Function in Mild Cognitive Impairment

Methylphenidate and Response to Alcohol Cues Pilot Study

A Study Using Functional Magnetic Resonance Imaging (fMRI) to Assess the Effects of Naltrexone SR/ Bupropion SR Therapy in Overweight or Obese Subjects

Oxytocin and Cognitive Behavioral Therapy in Drug Dependence

fMRI Neurofeedback With Matter Neuroscience App

Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction

Cognitive Effects of Exercise in Parkinson's Disease

Development of Techniques for Use in MRI With a Magnetic Field of 7 Tesla

Effect of Hyperbaric Oxygen on Functional Connectivity in Patients With Cerebral Small Vessel Disease

Brain Imaging in Men With Lower Urinary Tract Symptoms

Improving Therapeutic Outcomes in the Tongue Carcinoma Patient: Assessment of Adaptation Using Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging

Effect of 8-Week Dietary DHA Supplementation on Cerebral Blood Flow and Metabolic Function